NGL Fine-Chem Limited (NGLFINE)
Investor Presentation
AI summary
- Q2FY27 revenue grew 32% y-y to ₹158.7 Cr; EBITDA margin improved 341 bps y-y to 17.7%
- Phase II plant commissioned; utilization to reach 30-40% in 2-3 quarters, weighing on margins short term
- New capacity targets unregulated markets; regulatory filings underway for Europe and US by end-2027
- Animal API segment remains dominant with 95% production; strong global presence and customer base
- Brownfield and greenfield expansions underway with ₹220 Cr capex funded by debt and accruals
- Management confident of profitable growth medium term despite near-term margin pressure
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 NGLFINE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add NGLFINE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on NGL Fine-Chem Limited
Important.
The summary above is generated automatically from NGL Fine-Chem Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.